How to Read a Peptide Certificate of Analysis (COA)

A certificate of analysis (COA) is a document that reports analytical information associated with a particular sample or lot. It is not a clinical leaflet and not an authorization for use. It is a laboratory report: it identifies the material, the test, and the results the laboratory recorded.

For research materials, a COA helps a reader see what was measured and how that portion was identified. Peptra Health publishes available certificates in the COA verification archive, organized by compound and lot.

What a certificate of analysis is

In quality documentation, a report of analysis often includes the material name, lot or batch number, release or report date, and a list of tests with acceptance limits and numerical results where applicable. FDA summarizes this practice, in the CGMP component context, by pointing to ICH Q7 recommendations for the contents of a COA.

That does not mean every research-peptide COA follows an official pharmaceutical template. The document should be read for what it shows: the laboratory’s fields, methods, and figures.

Compound or sample identification

The report should state what was analyzed. It may list a compound name, a sample description, or both. If the name on the report does not match the material under review, the remaining results do not describe that portion.

Document identification is not the same as an identity test. It only locates the report. Identity confirmation, when present, appears as a separate analytical result.

Lot identifier

The lot (sometimes called a batch in other documents) is the link between the report and a specific portion of material. Two vials of the same compound can belong to different lots and therefore to different reports.

The lot shown on a Peptra certificate is transcribed from the laboratory report. It should not be confused with other commercial catalog codes. Each HTML certificate page uses the analytical lot, for example in Retatrutida documentation.

Certificate or report number

The accession or certificate number identifies the report in the laboratory’s system. It is distinct from the lot and from a search code, if the laboratory publishes one. Each field answers a different question: which material, which document, and how to look it up.

Laboratory identity

The COA should state who performed the analysis. On certificates published by Peptra, the analytical laboratory is independent: Peptra does not present those results as if they were measured in-house.

The laboratory name alone does not imply a specific accreditation, country, or scope that the report does not declare. Only information supported by the document should be stated.

Report date

The report date places the test in time. It describes the material under the conditions of that test. It does not demonstrate later stability, or storage conditions after the material left the laboratory.

Analytical method

A result is interpreted together with the method that produced it. ICH Q2(R2) states that analytical-procedure validation is intended to show that the procedure is fit for its intended purpose. Purpose matters: a method designed for purity does not, by itself, answer sterility or identity.

If the report names HPLC, LC-MS, or another technique, that label limits the kind of information available. A comparison of those two techniques is in HPLC vs LC-MS in peptide analysis.

Reported purity

The purity figure on the certificate is a reported result under the stated assay. It should not be rounded or “improved” when transcribed. Peptra pages show it as reported purity, not as an independent Peptra guarantee.

A high percentage does not demonstrate safety, sterility, absence of endotoxins, correct dosing, or suitability for human use. Those properties require other tests, when they exist, and are not inferred from purity alone. What does 99% peptide purity mean? develops that distinction.

Identity confirmation

When a report includes identity, it is usually based on a technique that supplies structural or mass information, not only on the printed name. FDA and ICH treat identity and purity as distinct attributes: a material can be identified and, separately, characterized for impurities.

If the certificate does not document an identity test, identity confirmation should not be claimed.

Purity versus quantity or content

Purity and content are not the same datum. Purity describes, within the method, the relative fraction of the specified component among what the assay observes. Content or quantity refers to how much material is present relative to a label or a mass.

A 99% purity result does not automatically mean that 99% of the vial mass is the peptide of interest. It also does not replace a net-content assay if that assay is absent from the report.

Why the lot on the certificate matters

The lot is the unit that connects material to report. A COA from another lot, even for the same compound, describes a different portion. That is why Peptra’s archive is organized as compound → lot → original document, not as a single certificate “for the product.”

When evaluating a material, the lot on the vial or label should be associable with the lot on the report. Without that correspondence, the COA does not document that unit.

How Peptra organizes certificates

Peptra publishes an HTML page for each lot, with fields transcribed from the certificate record, and keeps the laboratory PDF as the original document. The entry point is Verify COA. Each compound has an archive, for example Retatrutida certificates.

That structure makes it easier to review the correct lot. It does not turn the certificate into a sales sheet. The commercial product page, when it exists, is a separate resource: view Retatrutida documentation.